Drug intelligence / Profile preview

Cystolib Nutra

Development stage: Unknown
Lead developer: Charak
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Cystolib Nutra is a proprietary Ayurvedic nutritional supplement developed by Charak Pharma to support women's reproductive health, particularly those suffering from Polycystic Ovary Syndrome (PCOS). The formulation combines herbal extracts, such as Aloe vera (Aloe barbadensis) and Cinnamon (Cinnamomum zeylanicum), with essential micronutrients, vitamins, and minerals including myo-inositol, folic acid, vitamin D3, zinc, calcium, and magnesium. It is designed to help restore hormonal balance, improve ovarian function, regulate the menstrual cycle, enhance insulin sensitivity, and support metabolic health.

Brand names: Cystolib NutraCystolib Nutra TabletCystolib Nutra Women's Tablet

Beyond the preview

Go deeper on Cystolib Nutra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cystolib Nutra.